Rapid Micro Biosystems第四季度每股收益$(0.22)优于预期$(0.23),销售额$822万超预期$780万

财报速递
02-28
Rapid Micro Biosystems (NASDAQ:RPID)报告季度每股亏损$(0.22),优于分析师普遍预期的$(0.23),增长了4.35%。这相比去年同期每股亏损$(0.26)增加了15.38%。公司报告季度销售额为822万美元,超出分析师普遍预期的780万美元,增长了5.36%。这比去年同期634万美元的销售额增长了29.68%。

以上内容来自Benzinga Earnings专栏,原文如下:

Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $8.22 million which beat the analyst consensus estimate of $7.80 million by 5.36 percent. This is a 29.68 percent increase over sales of $6.34 million the same period last year.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10